Ambani Orgochem EGM Advances Capital Recast in 2026

Ambani Orgochem Limited held an Extraordinary General Meeting on October 26, 2026, to consider changes to its authorised share capital and governing documents. The meeting followed a board decision on September 28 to consider fund raising through instruments such as equity shares, warrants and debt securities. The company also released its H1 FY27 investor presentation on October 26, reporting revenue growth of 54.87% and outlining capacity expansion plans. The disclosed EGM agenda is important because it set out the corporate actions needed for a proposed preferential issue of convertible warrants.

EGM held through video conference

The EGM was held through video conferencing and other audio-visual means at 3 pm on October 26. The company said the meeting was conducted in line with relevant Ministry of Corporate Affairs and Securities and Exchange Board of India circulars. The notice described several special businesses, including a capital reclassification and amendments to the Memorandum and Articles of Association. On October 27, Ambani Orgochem informed the exchange about an amendment to its AOA and MOA. The disclosure records the next step in updating the company’s constitutional documents.

Authorised capital reclassification proposed

Ambani Orgochem’s authorised share capital was stated at Rs 20 crore before the proposed reclassification. It was divided into 1.3 crore equity shares of face value Rs 10 each and 70 lakh unissued preference shares of face value Rs 10 each. The board proposed reclassifying the 70 lakh preference shares into 70 lakh equity shares. This would keep the aggregate authorised capital unchanged at Rs 20 crore. But it would alter the composition of the capital entirely toward equity shares.

Equity share capacity rises to two crore shares

Following the proposed reclassification, the authorised capital would consist of two crore equity shares of face value Rs 10 each. The company proposed replacing Clause IV, the capital clause, of its Memorandum of Association to reflect this structure. The move does not by itself issue new shares or change the total authorised capital. It increases the authorised equity-share capacity available for potential future equity-linked issuances. The reclassification required shareholder approval under Sections 13 and 61 of the Companies Act, 2013, according to the explanatory statement.

Proposed preferential warrants issue

The board meeting held on September 28 approved, subject to member and other required approvals, a proposed issue of up to 43.95 lakh convertible share warrants. Each warrant carries the right to subscribe to one equity share with a face value of Rs 10. The stated issue price was Rs 100 per warrant, comprising a Rs 10 face value and a Rs 90 premium. At the indicated price, the full proposed warrant issue represents a potential value of Rs 43.95 crore. The warrants were proposed for promoter and/or non-promoter allottees on a preferential basis.

Fund-raising options considered by board

The board meeting notice dated September 23 and scheduled for September 28 stated that the company would consider fund raising through one or more instruments. The listed routes included equity shares, convertible or non-convertible securities, warrants, debt securities, preferential issue, private placement and rights issue. The company noted that any such action would remain subject to applicable regulatory and statutory approvals, including shareholder approval where required. The later EGM notice specifically detailed the proposed convertible warrants. The disclosures therefore link the proposed capital reclassification with the company’s broader financing options.

AOA to adopt Companies Act Table F

The EGM agenda also included a proposal to adopt Table F of Schedule I of the Companies Act, 2013 as the company’s Articles of Association. The proposed amended AOA would replace the existing articles. Such an amendment is a corporate-governance and documentation measure, requiring a special resolution from shareholders. The company said the board had recommended the proposal. Its October 27 exchange filing referred to the amendment of the AOA and MOA.

Recent corporate actions provide context

Ambani Orgochem was formerly known as Ambani Organics Limited. The company’s earlier name-change proposal stated that the board had approved the change in February 2024, subject to shareholder and regulatory approvals. The Central Registration Centre had confirmed the availability of the new name in March 2024, according to the company’s disclosure. The 2026 notices and filings use Ambani Orgochem Limited as the company name. This background explains why some notices continue to refer to the former name.

AGM resolutions were passed in September

Before the EGM, Ambani Orgochem held its 40th Annual General Meeting on September 26, 2026. The company subsequently said that members passed all eight items in the AGM notice. The voting results and scrutiniser’s report were dated September 28. The AGM and EGM were separate shareholder meetings, with the latter focused on the capital structure, proposed warrants and constitutional document changes. Investors should distinguish between resolutions confirmed at the AGM and proposals described in the EGM notice.

Key disclosed figures

Market relevance for investors

The capital reclassification does not alter the company’s total authorised capital of Rs 20 crore. Its practical effect is to make the full authorised capital available in equity-share form rather than retaining a preference-share component. The proposed warrant issue, if completed under the stated terms, could result in an equivalent number of equity shares upon conversion. That makes the terms, approvals, allotment details and conversion process relevant for shareholders assessing the company’s capital structure. The company’s investor presentation also referred to capacity expansion plans, though the provided disclosure does not specify the projects, investment amount or implementation schedule.

What follows from the disclosures

Ambani Orgochem’s October actions combine a capital-structure recast with proposed equity-linked fund raising. The company has disclosed the reclassification of authorised capital, the related MOA and AOA amendments, and a proposed preferential warrant issue of up to 43.95 lakh warrants. The October 27 exchange filing confirmed an amendment to the company’s AOA and MOA. Further company disclosures would be needed to establish the final allotment, allottee details, conversion outcomes and use of funds associated with the proposed warrants.